biostudies-literatureCanzian FIntramural NIH HHSMedical Research CouncilNCI NIH HHS3873-84https://www.ebi.ac.uk/biostudies/studies/S-EPMC2935856biostudies-literatureUnknown19(19)There is extensive evidence that increases in blood and tissue concentrations of steroid hormones and of insulin-like growth factor I (IGF-I) are associated with breast cancer risk. However, studies of common variation in genes involved in steroid hormone and IGF-I metabolism have yet to provide convincing evidence that such variants predict breast cancer risk. The Breast and Prostate Cancer Cohort Consortium (BPC3) is a collaboration of large US and European cohorts. We genotyped 1416 tagging single nucleotide polymorphisms (SNPs) in 37 steroid hormone metabolism genes and 24 IGF-I pathway genes in 6292 cases of breast cancer and 8135 controls, mostly Caucasian, postmenopausal women from the BPC3. We also imputed 3921 additional SNPs in the regions of interest. None of the SNPs tested wasHuman molecular geneticsComprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.PMC2935856U01-CA98233G0401527U01-CA98758U01-CA98710U01-CA98216Diver WRBeckmann LBerg CDSetiawan VWFeigelson HSBuring JHankinson SEPeeters PHKaaks RThomas GClavel-Chapelon FKolonel LNHunter DJKhaw KTTrichopoulos DLe Marchand LCox DGLund ETjonneland AIsaacs CYeager MHoover RNThun MJHallmans GHusing AHaiman CARiboli EChanock SJOvervad KDeLancey JOZiegler RGTumino RBlanche HPollak MStram DOPanico SCalle EEBingham SBuys SSBarricarte AHenderson BEDorronsoro MDossus LKraft PCanzian FfalseComprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.There is extensive evidence that increases in blood and tissue concentrations of steroid hormones and of insulin-like growth factor I (IGF-I) are associated with breast cancer risk. However, studies of common variation in genes involved in steroid hormone and IGF-I metabolism have yet to provide convincing evidence that such variants predict breast cancer risk. The Breast and Prostate Cancer Cohort Consortium (BPC3) is a collaboration of large US and European cohorts. We genotyped 1416 tagging single nucleotide polymorphisms (SNPs) in 37 steroid hormone metabolism genes and 24 IGF-I pathway genes in 6292 cases of breast cancer and 8135 controls, mostly Caucasian, postmenopausal women from the BPC3. We also imputed 3921 additional SNPs in the regions of interest. None of the SNPs tested was2010-01-01T00:00:00Z2010 Oct2026-05-01T05:03:17.862Z2026-04-07T16:40:03.768ZS-EPMC29358562063419710.1093/hmg/ddq291